title: Afferent mechanism in the urinary tract.
abstract: Much of the current research on lower urinary tract dysfunction is focused on afferent mechanisms. The main goals are to define and modulate the signaling pathways by which afferent information is generated and conveyed to the central nervous system. Alterations in bladder afferent mechanisms are a potential source of voiding dysfunction and an emerging source of drug targets. Even some established drug therapies such as muscarinic receptor antagonists, as well as emerging therapies such as botulinum toxin type-A, may act partly through afferent mechanisms. This review presents up-to-date findings on the localization of afferent fiber types within the bladder wall, afferent receptors and transmitters, and how these may communicate with the urothelium, interstitial cells, and detrusor smooth muscle to regulate micturition in normal and pathological bladders. Peripheral and central mechanisms of afferent sensitization and myogenic mechanisms that lead to detrusor overactivity, overactive bladder symptoms, and urgency sensations are also covered as well as new therapeutic approaches and new and established methods of measuring afferent activity.
authors.affiliation: University of Pittsburgh, School of Medicine, Pittsburgh, PA15261, USA. ajk5@pitt.edu
authors.forename: Anthony J
authors.initials: AJ
authors.lastname: Kanai
mesh_terms: D000200:Action Potentials; D000344:Afferent Pathways / Q000187:drug effects / Q000503:physiopathology*; D000818:Animals; D006801:Humans; D018377:Neurotransmitter Agents / Q000627:therapeutic use; D018408:Patch-Clamp Techniques; D009435:Synaptic Transmission / Q000187:drug effects; D001743:Urinary Bladder / Q000294:innervation*; D014554:Urination; D014555:Urination Disorders / Q000188:drug therapy / Q000503:physiopathology*; D014563:Urodynamics; D019459:Urothelium / Q000294:innervation
chemical_list: D018377:Neurotransmitter Agents